Table 1.
Demographic characteristics and clinical features of participants.
| Parameters | HBV | HCV | Healthy controls |
|---|---|---|---|
| Number | 35 | 50 | 17 |
| Age (years) | |||
| Mean ± SD | 45 ± 10 | 43 ± 10 | 44 ± 9 |
| Median (range) | 40 (19–62) | 45 (27–69) | 49 (42–54) |
| Sex N (%) | |||
| Male | 30 (85,8) | 29 (48) | 9 (52,9) |
| Female | 5 (14,2) | 21 (42) | 8 (47,1) |
| Viremia (log10 copies/mL) | |||
| Median (range) | 8,4 (5,7–9,8)* | 5,9 (1,2–7,5)* | NA |
| ALT (U/L) | |||
| Median (range) | 219 (12–914)* | 44,1 (11,2–274,90)* | 16 (4–29) |
| AST (U/L) | |||
| Median (range) | 117 (22–221)* | 44,6 (13,9–262)* | 16 (8–32) |
| HBsAg (IU/mL) | |||
| Median (range) | 4697,68 (1243,65–55925,04)* | / | NA |
| HBsAb (mIU/mL) | |||
| Median (range) | 0,06 (0–3,71)* | NA | |
| HBeAg (S/CO) | |||
| Median (range) | 3233,3 (3,88–4094,10)* | / | NA |
| HBeAb (S/CO) | |||
| Median (range) | 16.74 (0,02–46,74)* | NA |
Normal values: ALT ≤ 40 IU/L; AST ≤ 40 IU/L; HBV DNA ≤ 3 log10copies/mL; HCV RNA ≤ 3 log10copies/mL; ∗ P < 0.05 HBV/HCV versus healthy controls.